These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 34019949)

  • 1. Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    Tsapepas D; Paget K; Mohan S; Cohen DJ; Husain SA
    Am J Kidney Dis; 2021 Aug; 78(2):314-317. PubMed ID: 34019949
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
    Boyarsky BJ; Barbur I; Chiang TP; Ou MT; Greenberg RS; Teles AT; Krach MR; López JI; Garonzik-Wang JM; Avery RK; Massie AB; Segev DL; Werbel WA
    Transplantation; 2021 Nov; 105(11):e270-e271. PubMed ID: 34284420
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.
    Haskin O; Ashkenazi-Hoffnung L; Ziv N; Borovitz Y; Dagan A; Levi S; Koren G; Hamdani G; Levi-Erez D; Landau D; Alfandary H
    Transplantation; 2021 Nov; 105(11):e226-e233. PubMed ID: 34381004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
    Al Jalali V; Scherzer S; Zeitlinger M
    Clin Microbiol Infect; 2021 Oct; 27(10):1529-1530. PubMed ID: 34192576
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.
    Chavarot N; Leruez-Ville M; Scemla A; Burger C; Amrouche L; Rouzaud C; Lebreton X; Martinez F; Sberro-Soussan R; Legendre C; Zuber J; Anglicheau D
    Kidney Int; 2021 Feb; 99(2):486-488. PubMed ID: 33509358
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.
    Stumpf J; Tonnus W; Paliege A; Rettig R; Steglich A; Gembardt F; Kessel F; Kröger H; Arndt P; Sradnick J; Frank K; Tonn T; Hugo C
    Transplantation; 2021 Nov; 105(11):e267-e269. PubMed ID: 34342963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.
    De Bouver C; Bouziotis J; Wijtvliet VPWM; Ariën KK; Mariën J; Heyndrickx L; Couttenye MM; de Fijter HJW; Mestrez F; Treille S; Mat O; Collart F; Allard SD; Vingerhoets L; Moons P; Abramowicz D; De Winter BY; Pipeleers L; Wissing KM; Ledeganck KJ
    Virol J; 2024 Jun; 21(1):138. PubMed ID: 38872127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
    Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
    J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
    Cheng Y-L; Chang S-S; Chao C-H; Chen P-T; Lin Y-L; Syu G-D; Lee N-Y; Chen P-L; Ko W-C; Ho T-S
    Microbiol Spectr; 2024 Jun; 12(6):e0000424. PubMed ID: 38747636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.
    Azzi Y; Parides M; Alani O; Loarte-Campos P; Bartash R; Forest S; Colovai A; Ajaimy M; Liriano-Ward L; Pynadath C; Graham J; Le M; Greenstein S; Rocca J; Kinkhabwala M; Akalin E
    Kidney Int; 2020 Dec; 98(6):1559-1567. PubMed ID: 33069762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very Low Immunization Rate in Kidney Transplant Recipients After One Dose of the BNT162b2 Vaccine: Beware not to Lower the Guard!
    Georgery H; Devresse A; Yombi JC; Belkhir L; De Greef J; Darius T; Buemi A; Scohy A; Kabamba B; Goffin E; Kanaan N
    Transplantation; 2021 Oct; 105(10):e148-e149. PubMed ID: 33988543
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
    Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
    Front Immunol; 2021; 12():728021. PubMed ID: 34646267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
    Ikizler TA; Coates PT; Rovin BH; Ronco P
    Kidney Int; 2021 Jun; 99(6):1275-1279. PubMed ID: 33931226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking care of kidney transplant recipients during the COVID-19 pandemic: Experience from a medicalized hotel.
    Cucchiari D; Guillén E; Cofan F; Torregrosa JV; Esforzado N; Revuelta I; Ventura-Aguiar P; Oppenheimer F; Bayés B; Marcos MÁ; Morgado-Carrasco D; López JM; Creus P; Hernández C; Coloma E; Bodro M; Diekmann F; Pericàs JM; Nicolás D;
    Clin Transplant; 2021 Jan; 35(1):e14132. PubMed ID: 33103277
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients.
    Crane C; Phebus E; Ingulli E
    Pediatr Nephrol; 2022 Feb; 37(2):449-453. PubMed ID: 34522992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.
    Capone M; Vanni A; Salvati L; Lamacchia G; Mazzoni A; Maggi L; Cosmi L; Liotta F; Romagnani P; Cirillo L; Buti E; Terlizzi V; Azzari C; Citera F; Barbati F; Rossolini GM; Bresci S; Borchi B; Cavallo A; Mencarini J; Francalanci E; Kiros ST; Bartoloni A; Annunziato F
    Immunol Lett; 2024 Aug; 268():106886. PubMed ID: 38906482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.